Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Ka Won Kang"'
Autor:
Sang Eun Yoon, Yuqin Song, Seok Jin Kim, Dok Hyun Yoon, Tsai-Yun Chen, Youngil Koh, Ka Won Kang, Ho Sup Lee, Kevin Kuang Wei Tay, Soon Thye Lim, Michele Poon, Cosphiadi Irawan, Weili Zhao, Young Rok Do, Mark Hong Lee, Soo Chin Ng, Won-Sik Lee, Ye Guo, Huilai Zhang, Hye Jin Kang, Hwan Jung Yun, Hyo Jung Kim, Daryl Tan Chen Lung, Jae-Yong Kwak, Jae Joon Han, Yeung-Chul Mun, Sung Yong Oh, Hyeok Shim, Jung Hye Kwon, Byeong Seok Sohn, Seong Kyu Park, Jae-Cheol Jo, Young Hyeh Ko, Zhu Jun, Won Seog Kim
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 10, Iss , Pp 100126- (2021)
Background: Peripheral T-cell lymphomas (PTCLs) are uncommon and their frequency is regionally heterogeneous. Several studies have been conducted to evaluate the clinical features and treatment outcomes of this disease entity, but the majority of the
Externí odkaz:
https://doaj.org/article/7bd9491e02234f29aebb00e8c11f836c
Autor:
Jongheon Jung, Sung-Hoon Jung, Je-Jung Lee, Young Rok Do, Ka-Won Kang, Jung Lim Lee, Sung-Soo Yoon, Chang-Ki Min, Hye Jin Kang, Ji Hyun Lee, Ju-Hyun Park, Kihyun Kim, Hyeon-Seok Eom, The Korean Multiple Myeloma Working Party (KMMWP)
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Tandem autologous stem cell transplantation can improve the prognosis of patients with multiple myeloma. However, the precise role of tandem transplantation remains debatable. We evaluated the clinical benefits of tandem transplantation retr
Externí odkaz:
https://doaj.org/article/5ee6223318964fd084fe2b2b29a41069
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin’s lymphoma, for which cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab(R–CHOP) is one of the standard regimens. Given that R–CHOP is
Externí odkaz:
https://doaj.org/article/bc94cd0b8d004c028e515c1d25aa9cda
Autor:
Woojin Back, Minseo Bang, Jik-Han Jung, Ka-Won Kang, Byeong Hyeon Choi, Yeonho Choi, Sunghoi Hong, Hyun Koo Kim, Yong Park, Ji-Ho Park
Publikováno v:
ACS Omega, Vol 9, Iss 16, Pp 17832-17838 (2024)
Externí odkaz:
https://doaj.org/article/e9216c852962493b9543b5e8e44e65e5
Autor:
Changhee Park, Ho Sup Lee, Ka-Won Kang, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok-Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung-Soo Yoon, Youngil Koh
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Potential synergism between Bruton’s tyrosine kinase (BTK) inhibitor and lenalidomide in treating aggressive B-cell lymphoma has been suggested. Here, the authors report a single-arm phase II clinical trial of combination of acalabrutinib,
Externí odkaz:
https://doaj.org/article/1be364a2c8774becbc1348fb645041c5
Publikováno v:
PLoS ONE, Vol 19, Iss 8 (2024)
Externí odkaz:
https://doaj.org/article/b5f4b0edc6f24279968558551f5ae3cc
Autor:
Hyungwoo Cho, Kihyun Kim, Sang Eun Yoon, Sung‐Hoon Jung, Je‐Jung Lee, Joon Ho Moon, Hee Jeong Cho, Ho Sup Lee, Ka‐Won Kang, Sung‐Yong Kim, Hyeon‐Seok Eom, Yeung‐Chul Mun, Young Hoon Park, Sung‐Soo Yoon, Young Rok Do, Won Sik Lee, Chang‐Ki Min, Dok Hyun Yoon
Publikováno v:
HemaSphere, Vol 8, Iss 1, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/83f0181575af46f6b195657a752b4626
Autor:
Minyoung Baik, Sanghoon Shin, Samir Kumar, Dongmin Seo, Inha Lee, Hyun Sik Jun, Ka-Won Kang, Byung Soo Kim, Myung-Hyun Nam, Sungkyu Seo
Publikováno v:
Biosensors, Vol 13, Iss 12, p 993 (2023)
Accurate and efficient classification and quantification of CD34+ cells are essential for the diagnosis and monitoring of leukemia. Current methods, such as flow cytometry, are complex, time-consuming, and require specialized expertise and equipment.
Externí odkaz:
https://doaj.org/article/b1287fd68f9443929aa51510c8659e21
Autor:
Ka-Won Kang, Byung-Hyun Lee, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Yong Park, Byung Soo Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 36, Iss 6, Pp 1459-1470 (2021)
Background/Aims Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphoma or multiple myeloma. We aimed to determine th
Externí odkaz:
https://doaj.org/article/baa0bf3f9f8840cba3280b086bacb16c
Publikováno v:
Stem Cell Research, Vol 65, Iss , Pp 102939- (2022)
Multiple myeloma (MM) progresses with abnormal monoclonal proliferation and accumulation of malignant plasma cells in the bone marrow. We established human induced pluripotent stem cells (iPSCs), KUMi005-A, from bone marrow samples of a patient with
Externí odkaz:
https://doaj.org/article/7be8891108aa47628008a997e535ad0f